Pyxis Oncology logo

Pyxis Oncology (PYXS) Q2 2024 Earnings

PYXS·Reported August 14, 2024·Before market open

Diluted EPS came in at $-0.29, beat the $-0.33 consensus by $0.04.

Diluted EPS
$-0.29beat by $0.04
Consensus: $-0.33
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q2 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Pyxis Oncology's Q2 2024 earnings report.

Pyxis Oncology (PYXS) reported Q2 2024 earnings on August 14, 2024 before market open.

Pyxis Oncology reported diluted EPS of $-0.29 for Q2 2024.

EPS beat the consensus estimate of $-0.33 by $0.04.

You can read the 10-Q periodic report (0000950170-24-097073) directly on SEC EDGAR. The filing index links above go to sec.gov.